{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:44:18Z","timestamp":1772837058923,"version":"3.50.1"},"reference-count":32,"publisher":"Georg Thieme Verlag KG","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1055\/a-2057-1761","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T22:48:53Z","timestamp":1722638933000},"page":"941-947","source":"Crossref","is-referenced-by-count":1,"title":["Akute Virushepatitis"],"prefix":"10.1055","volume":"149","author":[{"given":"Katja","family":"Deterding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.182.4116.1026","article-title":"Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness","volume":"182","author":"SM Feinstone","year":"1973","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00103-021-03478-8","article-title":"Epidemiologie der Virushepatitiden A bis E in Deutschland","volume":"65","author":"S Dudareva","year":"2021","journal-title":"Bundesgesundheitsblatt"},{"issue":"06","key":"ref3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00108-004-1197-4","article-title":"Hepatitis as a travel disease","volume":"45","author":"J Hadem","year":"2004","journal-title":"Der Internist"},{"key":"ref4","volume-title":"Immunopathogenesis and treatment of hepatitis A. Liver Immunology","author":"ME Gershwin","year":"2003"},{"issue":"05","key":"ref5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/v15051080","article-title":"Treatment Options for Hepatitis A and E: A Non-Systematic Review","volume":"15","author":"F Gabrielli","year":"2023","journal-title":"Viruses"},{"issue":"17","key":"ref6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1056\/NEJM198510243131706","article-title":"Type A viral hepatitis. New developments in an old disease","volume":"313","author":"SM Lemon","year":"1985","journal-title":"N Engl J Med"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1055\/s-2003-42929","article-title":"Immunogenicity of an accelerated vaccination regime with a combined hepatitis a\/b vaccine in patients with chronic hepatitis C","volume":"41","author":"B Kallinowski","year":"2003","journal-title":"Z Gastroenterol"},{"issue":"07","key":"ref8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1055\/a-1498-2512","article-title":"Not Available","volume":"59","author":"M Cornberg","year":"2021","journal-title":"Z Gastroenterol"},{"key":"ref10","first-page":"203","article-title":"Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations","volume":"8","author":"G Colloredo Mels","year":"1993","journal-title":"Arch Virol Suppl"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2893.2005.00695.x","article-title":"Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience","volume":"13","author":"HL Tillmann","year":"2006","journal-title":"J Viral Hepat"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1055\/s-0042-120418","article-title":"Treatment of fulminant acute Hepatitis B with nucles(t)id analogues is safe and does not lead to secondary chronification of Hepatitis B","volume":"54","author":"C Jochum","year":"2016","journal-title":"Z Gastroenterol"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1478-3231.2011.02450.x","article-title":"Lamivudine treatment is associated with improved survival in fulminant hepatitis B","volume":"31","author":"JW Yu","year":"2011","journal-title":"Liver Int"},{"issue":"24","key":"ref14","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1001\/jama.2023.23242","article-title":"Hepatitis D: A Review","volume":"330","author":"F Negro","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"ref16","first-page":"1165","article-title":"Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?","volume":"48","author":"A Kubitschke","year":"2007","journal-title":"Internist"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"QL Choo","year":"1989","journal-title":"Science"},{"issue":"S 01","key":"ref18","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/jhep.2002.36227","article-title":"Course and outcome of hepatitis C","volume":"36","author":"JH Hoofnagle","year":"2002","journal-title":"Hepatology"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"J Grebely","year":"2012","journal-title":"Lancet"},{"issue":"06","key":"ref20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1055\/s-0028-1109149","article-title":"The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection","volume":"47","author":"K Deterding","year":"2009","journal-title":"Z Gastroenterol"},{"issue":"S 03","key":"ref21","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/cid\/ciad380","article-title":"Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review","volume":"77","author":"CC Hsu","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/jhep.2003.50310","article-title":"Kinetics of the immune response during HBV and HCV infection","volume":"38","author":"A Bertoletti","year":"2003","journal-title":"Hepatology"},{"issue":"20","key":"ref23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"E Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"J Wiegand","year":"2006","journal-title":"Hepatology"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1473-3099(13)70059-8","article-title":"Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial","volume":"13","author":"K Deterding","year":"2013","journal-title":"Lancet"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1473-3099(16)30408-X","article-title":"Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study","volume":"17","author":"K Deterding","year":"2017","journal-title":"Lancet"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"100650","DOI":"10.1016\/j.jhepr.2022.100650","article-title":"Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study","volume":"5","author":"B Maasoumy","year":"2023","journal-title":"JHEP Rep"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1055\/a-1226-0241","article-title":"Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion","volume":"58","author":"C Sarrazin","year":"2020","journal-title":"Z Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3238\/arztebl.2014.0577","article-title":"Hepatitis E in Germany--an under-reported infectious disease","volume":"111","author":"S Pischke","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"06","key":"ref30","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/v15061389","article-title":"Hepatitis E Virus Infections: Epidemiology, Genetic Diversity, and Clinical Considerations","volume":"15","author":"B Songtanin","year":"2023","journal-title":"Viruses"},{"issue":"05","key":"ref31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/apt.13938","article-title":"Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection","volume":"45","author":"S Zhang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"06","key":"ref32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","article-title":"Pathogenesis and treatment of hepatitis e virus infection","volume":"142","author":"H Wedemeyer","year":"2012","journal-title":"Gastroenterology"},{"issue":"18","key":"ref33","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3748\/wjg.v27.i18.2090","article-title":"Neurological manifestations of hepatitis E virus infection: An overview","volume":"27","author":"AK Jha","year":"2021","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1473-3099(16)30408-X","article-title":"Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study","volume":"17","author":"K Deterding","year":"2017","journal-title":"Lancet Infect. Dis."}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2057-1761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:10:25Z","timestamp":1730812225000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2057-1761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8,2]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2057-1761","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}